Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile Acids

por Guidetti, Lorenzo, Castelli, Riccardo, Scalvini, Laura, Ferlenghi, Francesca, Corrado, Miriam, Giorgio, Carmine, Tognolini, Massimiliano, Lodola, Alessio
Publicado 2022

A Pharmacological Investigation of Eph-Ephrin Antagonism in Prostate Cancer: UniPR1331 Efficacy Evidence

por Festuccia, Claudio, Corrado, Miriam, Rossetti, Alessandra, Castelli, Riccardo, Lodola, Alessio, Gravina, Giovanni Luca, Tognolini, Massimiliano, Giorgio, Carmine
Publicado 2023

Evaluation of the Anti-Tumor Activity of Small Molecules Targeting Eph/Ephrins in APC (min)/J Mice

por Corrado, Miriam, Giorgio, Carmine, Barocelli, Elisabetta, Marzetti, Giuseppe Vittucci, Cantoni, Anna Maria, Di Lecce, Rosanna, Incerti, Matteo, Castelli, Riccardo, Lodola, Alessio, Tognolini, Massimiliano
Publicado 2020

Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin

por Rusnati, Marco, Paiardi, Giulia, Tobia, Chiara, Urbinati, Chiara, Lodola, Alessio, D’Ursi, Pasqualina, Corrado, Miriam, Castelli, Riccardo, Wade, Rebecca C., Tognolini, Massimiliano, Chiodelli, Paola
Publicado 2021

Correction: Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin

por Rusnati, Marco, Paiardi, Giulia, Tobia, Chiara, Urbinati, Chiara, Lodola, Alessio, D’Ursi, Pasqualina, Corrado, Miriam, Castelli, Riccardo, Wade, Rebecca C., Tognolini, Massimiliano, Chiodelli, Paola
Publicado 2021